<DOC>
	<DOCNO>NCT02568254</DOCNO>
	<brief_summary>This single-site , 8-visit , double-masked , cross-over study involve three market product study lens . Participants randomly assign lens type , wear approximately two week ( 12 +/- 2 day ) . Participants undergo minimum washout period 3 day enter study undergo minimum 7 day washout period dispense lens type .</brief_summary>
	<brief_title>Clinical Evaluation Investigational Contact Lenses</brief_title>
	<detailed_description />
	<criteria>The subject must read , understand , sign STATEMENT OF INFORMED CONSENT receive fully execute copy form ; The subject must appear able willing adhere instruction set forth clinical protocol ; The subject must willing able follow instruction maintain appointment schedule ; The subject must age 18 40 year ( inclusive ) ; The subject 's vertex correct spherical equivalent distance refraction must range 0.50 Diopters ( D ) 6.00 D eye ( inclusive ) ; The subject 's refractive cylinder must exceed 1.25 Diopters Cylinder ( DC ) eye vertexing corneal plane ; The subject must best correct visual acuity 0.2 Logarithm Minimum Angle Resolution ( logMAR ) good eye ; The subject must current wearer spherical , soft contact lens ( toric , bifocal multifocal contact lens , extend wear monovision ) least 5 days/week least 8 hours/day month prior enrollment ; The subject must wearable pair spectacle wear day initial visit ; The subject must exist wearer spherical , soft contact lenses eye ; The subject must normal eye ( i.e. , ocular medication infection type ) ; The subject must willing wear study lenses minimum eight hour per day . Any ocular systemic allergy disease may interfere contact lens wear ( investigator 's discretion ) ; Any systemic disease , autoimmune disease , use medication , may interfere contact lens wear ( investigator 's discretion ) ; Currently pregnant lactate ( subject become pregnant study discontinue ) ; Any infectious disease ( e.g. , hepatitis , tuberculosis ) contagious immunosuppressive disease ; Any active ocular infection ; Is use topical medication ( exclude artificial tear ( ATS ) ) two week prior screen visit ; Any participant whose habitual contact lens use extend wear regimen ; Entropion , ectropion , extrusion , chalazia , recurrent stye , glaucoma , history recurrent corneal erosion , aphakia , moderate corneal distortion keratometry ; Any previous , plan , ocular interocular surgery ( e.g. , radial keratotomy , photorefractive keratectomy ( PRK ) , laserassisted situ keratomileusis ( LASIK ) , etc . ) ; Clinically significant ( grade 3 4 ) corneal edema , corneal vascularization , corneal staining , abnormality cornea would contraindicate contact lens wear ; clinically significant ( grade 3 4 ) tarsal abnormality bulbar injection might interfere contact lens wear ; Any known hypersensitivity allergic reaction study product ; Participation contact lens lens care product clinical trial within 7 day prior study enrollment ; Employee family member Centre Contact Lens Research ( e.g. , Investigator , Coordinator , Technician ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>